Investment firm Albion Ventures has added MyMeds&Me to its portfolio through a £2 million transaction.
A £125,000 equity investment allocation has been secured by LumbaCurve International to aid in its efforts to conduct market development and a clinical effectiveness study for its lower back pain treatment.
An investment of €1 million (£854,000) is set to allow biotech business Algae Health to recruit an extra 23 people in the coming three years.
Asalus Medical Instruments has raised £1.25 million ahead of the launch of its Ultravision technology in the second half of 2013.
An equity investment of £150,000 has been netted by healthcare technology business Med ePad.
NGBI Private Equity portfolio business Horizon Care has made a bolt-on acquisition with the help of its backer.
Private equity firm August Equity has landed its first investment of 2013 by acquiring a stake in Compass Services for Children Group.
A seven-figure investment has been secured by Fertility Focus from a group of backers including Midven's Exceed Fund and the Angel CoFund.
A Scottish biomedical company has received the support of a number of equity backers as it looks to continue with the commercialisation of its products.
Venn Life Sciences has joined the Alternative Investment Market and raised growth funds to support the move.
EpiStem, a biotechnology and personalised medicine company, has used its Alternative Investment Market listing to raise £4.3 million.
Personalised nicotine patch business TTS Pharma has received investment from regional backer The North West Fund for Biomedical.
The government's Biomedical Catalyst is set to plough £39 million into the healthcare sector as part of its latest allocation.
An equity investment of £1.6 million is set to allow Qinec to expand its management team and develop its product portfolio.
UK-based biotech start-up Ziarco has closed the first tranche of what it reveals will be a £16.8 million Series A funding round.
Zilico has added to the £1 million investment it netted in June 2012 by securing a further £750,000.
AIM-listed Alliance Pharma has closed its second acquisition of 2012 through the purchase of Opus Group.
August Equity has sold portfolio company Enara having led the business through a buy-and-build growth strategy since 2008.
A newly-formed Scottish biotech company has secured the backing it needs to develop its tooth decay assessment technology.
A 25th investment for the North West Fund for Biomedical has seen BiOxyDyn secure the funds it needs to grow.
With its commercial activities taking it into many countries and communities around the world, brewery company SABMiller is supporting entrepreneurs to build their own enterprises.
Jude Harrison, SEO account manager at Steak Group, recalls his business conference nightmares and advises on how to avoid the same pitfalls.
The rise of crowdfunding can only be sustained if we keep the nanny state out.
New research from GrowthBusiness shows that the number of UK cash shells is climbing. We speak to new entrants to the market and those that have recently closed deals to find out what’s driving shells’ increasing popularity.